Hepatitis B virus precore/core variation and interferon therapy

Hepatology

Volumn 22, Issue 5, 1995, Pages 1355-1362

  Fattovich, Giovanna ^a   Mcintyre, Graham ^b   Thursz, Mark ^c   Colman, Kathryn ^b   Giuliano, Giustina ^d   Alberti, Alfredo ^d   Thomas, Howard C ^c   Carman, William F ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b INSTITUTE OF VIROLOGY   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Istituto di Medicina Clinica Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; EPITOPE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CORE; VIRUS GENOME; VIRUS MUTANT;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS; VIRAL CORE PROTEINS;

EID: 0028803193     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90136-1     Document Type: Article

References (34)

1. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B
2. Chronic hepatitis in HBeAg carriers with serum HBV-DNA and anti-HBe
3. Analysis of liver disease, nuclear HBeAg, viral replication and hepatitis B virus in liver and serum of HBeAg vs. anti-HBe positive chronic hepatitis B virus infection
4. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum
5. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis e antigen
6. Interferon alfa-2b treatment of HBeAg negative/ serum HBV DNA positive chronic active hepatitis type B
7. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg
8. Hepatitis B viruses with pre-core region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen
9. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity
10. Mutation preventing formation of e antigen in patients with chronic HBV infection
11. Identification of HBV variants which cannot produce precore-derived HBeAg and may be responsible for severe hepatitis
12. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum
13. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy
14. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha
15. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B
16. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance
17. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus
18. Identification of a major hepatitis B core antigen (HBeAg) determinant by using synthetic peptides and monoclonal antibodies
19. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen
20. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen
21. HLA A31 and HLA AW68 restricted cytotoxic T-cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis
22. Variations in codons 84–101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection
23. Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers
24. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis
25. HBeAg negative chronic active hepatitis: HBV core mutations occur predominantly in known antigenic determinants
26. Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B
27. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole
28. Pre-core sequence variation in Chinese isolates of hepatitis B virus
29. Further characterization of two types of pre-core variant HBV isolates from Hong Kong
30. Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection
31. Properties of hepatitis B virus pre-S1 deletion mutants
32. Frequent and rapid emergence of mutated Pre-C sequences in HBV from e-antigen positive carriers who seroconvert to antiHBe during interferon treatment
33. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
34. Genomic variations in the hepatitis B core gene: A possible factor influencing response to interferon alfa treatment